3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Publication
, Journal Article
Sanders, DB; Howard, JF; Massey, JM
Published in: Ann N Y Acad Sci
June 21, 1993
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann N Y Acad Sci
DOI
ISSN
0077-8923
Publication Date
June 21, 1993
Volume
681
Start / End Page
588 / 590
Location
United States
Related Subject Headings
- Myasthenia Gravis
- Lambert-Eaton Myasthenic Syndrome
- Humans
- General Science & Technology
- Double-Blind Method
- Amifampridine
- 4-Aminopyridine
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanders, D. B., Howard, J. F., & Massey, J. M. (1993). 3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis. Ann N Y Acad Sci, 681, 588–590. https://doi.org/10.1111/j.1749-6632.1993.tb22949.x
Sanders, D. B., J. F. Howard, and J. M. Massey. “3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis.” Ann N Y Acad Sci 681 (June 21, 1993): 588–90. https://doi.org/10.1111/j.1749-6632.1993.tb22949.x.
Sanders DB, Howard JF, Massey JM. 3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis. Ann N Y Acad Sci. 1993 Jun 21;681:588–90.
Sanders, D. B., et al. “3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis.” Ann N Y Acad Sci, vol. 681, June 1993, pp. 588–90. Pubmed, doi:10.1111/j.1749-6632.1993.tb22949.x.
Sanders DB, Howard JF, Massey JM. 3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis. Ann N Y Acad Sci. 1993 Jun 21;681:588–590.
Published In
Ann N Y Acad Sci
DOI
ISSN
0077-8923
Publication Date
June 21, 1993
Volume
681
Start / End Page
588 / 590
Location
United States
Related Subject Headings
- Myasthenia Gravis
- Lambert-Eaton Myasthenic Syndrome
- Humans
- General Science & Technology
- Double-Blind Method
- Amifampridine
- 4-Aminopyridine